On this episode I discuss roflumilast (Daliresp) pharmacology, adverse effects, and important drug interactions.
Roflumilast is indicated to reduce the incidence of COPD exacerbations.
Roflumilast is significantly broken down by CYP3A4 so there are numerous drug interactions that we have to take into account.
Psychiatric issues, GI upset, and weight loss are all potential adverse effects due to roflumilast.
Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!